Abstract:Background: Hyperhomocysteinemia (HHcy) is related to liver diseases, such as nonalcoholic fatty liver (NAFL). Although the precise pathogenesis of NAFL is still largely unknown, the links between organs seem to play a vital role. The current study aimed to explore the role of white adipose tissue in homocysteine (Hcy)-induced NAFL. Methods: Blood samples from nonhyperhomocysteinemia or hyper-homocysteinemia individuals were collected to assess correlation between Hcy and TG or FFAs levels. C57BL/6 mice were maintained on a high-methionine diet or administered with Hcy (1.8 g/l) in the drinking water to establish an HHcy mouse model. Lipolytic response was measured in adipose tissue or 3T3L-1 cells. Hif1a∆adipo mice and lentivirus construction were employed for mechanistic studies. Findings: We demonstrated that Hcy activated adipocyte lipolysis and that this change was accompanied by an increased release of fatty acids (FAs) and glycerol. Excessive FAs were taken up by hepatocyte, which resulted in lipid accumulation in the liver. Treatment with acipimox (0.08 g kg −1 day−1), a potent chemical inhibitor of lipolysis, markedly decreased the Hcy-induced NAFL. Mechanistically, hypoxia-inducible factor 1α (HIF1α)-endoplasmic reticulum oxidoreductin 1α (ERO1α) mediated pathway promoted ROS accumulation and induced ER overoxidation, ER stress and more closed ER-lipid droplet interactions, which were responsible for activating the lipolysis response. Specific disruption of adipocyte HIF1α reversed Hcy-induced lipolysis and alleviated the excess hepatic TG content. Interpretation: This study reveals that Hcy activates lipolysis via adipocyte HIF1α-ERO1α-mediated pathway and suggests the potential utility of targeted adipocyte HIF1α inhibition for treating Hcy-induced NAFL. Funding Statement: This work was supported by the National Natural Science Foundation of the People’s Republic of China (No. 31872787, 91739303, 91857115, 31925021, and 31771261) and the Youth Innovation Promotion Association, CAS (to LW). Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: Plasma was obtained from 38 individuals with hyperhomocysteinemia and 52 nonhyperhomocysteinemia from Peking University Third Hospital and was approved by the Ethics Committee of Peking University Third Hospital. Informed consent prior to participation was provided by all subjects. All animal studies were performed in compliance with the guidelines of the Institute of Laboratory Animal Resources and were approved by the Animal Care and Use Committee of Peking University.

Adipocyte-derived Lysophosphatidylcholine Activates Adipocyte and Adipose Tissue Macrophage Nod-Like Receptor Protein 3 Inflammasomes Mediating Homocysteine-Induced Insulin Resistance

Omega-3FAs Can Inhibit the Inflammation and Insulin Resistance of Adipose Tissue Caused by HHcy Induced Lipids Profile Changing in Mice

Hyperhomocysteinemia Promotes Insulin Resistance by Inducing Endoplasmic Reticulum Stress in Adipose Tissue

Macrophage HIF-2α suppresses NLRP3 inflammasome activation and alleviates insulin resistance

Macrophage CGI-58 Deficiency Activates ROS-inflammasome Pathway to Promote Insulin Resistance in Mice.

Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2

Homocysteine upregulates resistin production from adipocytes in vivo and in vitro

Regulation Of Insulin Resistance And Adiponectin Signaling In Adipose Tissue By Liver X Receptor Activation Highlights A Cross-Talk With Ppar Gamma

Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner

NLRP3 inflammasome mediate palmitate-induced endothelial dysfunction

Homocysteine Promotes Hepatic Steatosis by Activating the Adipocyte HIF1α-ERO1α-Lipolysis Pathway

Nuclear Factor Erythroid 2-Related Factor 2 Activation Mediates Hyperhomocysteinemia-Associated Lipolysis Suppression in Adipocytes.

Macrophage Alpha 1 Amp-Activated Protein Kinase (alpha 1ampk) Antagonizes Fatty Acid-Induced Inflammation Through Sirt1

<strong><b></b></strong>Impaired Adipose Tissue Expansion Caused by LXR Activation is Associated with Insulin Resistance in HFD Mice

Su1795 Uric Acid Regulates Hepatic Steatosis and Insulin Resistance Through the NLRP3 Inflammasome Dependent Mechanism

Adipocyte promotes adipose tissue inflammation and insulin resistance by modulating macrophages in obesity

The ATP-P2X7 Signaling Axis Is Dispensable for Obesity-Associated Inflammasome Activation in Adipose Tissue

High Endogenously Synthesized N-3 Polyunsaturated Fatty Acids in Fat-1 Mice Attenuate High-Fat Diet-Induced Insulin Resistance by Inhibiting NLRP3 Inflammasome Activation via Akt/GSK-3β/TXNIP Pathway

Endothelial Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Regulation in Atherosclerosis.

Obesity enables NLRP3 activation and induces myocardial fibrosis via hyperacetylation of HADHa

Adipocyte-Derived Exosomes Carrying Sonic Hedgehog Mediate M1 Macrophage Polarization-Induced Insulin Resistance Via Ptch and PI3K Pathways.